World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Aurinia Pharmaceuticals

    World Rank (Jan-05-2024)
    7,666
    Market Cap (Jan-05-2024)
    1.213 Billion USD
    World Rank (Jul-30-2023)
    6,232
    Market Cap (Jul-30-2023)
    1.755 Billion USD
    World Rank (Dec-25-2022)
    10,850
    Market Cap (Dec-25-2022)
    0.644 Billion USD
    World Rank (Jan-07-2022)
    5,556
    Market Cap (Jan-07-2022)
    2.44 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    Aurinia Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company developing in voclosporin, an investigational therapy for the treatment of lupus nephritis and other proteinuric diseases. The headquarters is in Canada.
    Company Website
    AURINIA PHARMACEUTICALS

  2. Autolus Therapeutics

    World Rank (Jan-05-2024)
    7,827
    Market Cap (Jan-05-2024)
    1.170 Billion USD
    World Rank (Jul-30-2023)
    12,973
    Market Cap (Jul-30-2023)
    0.483 Billion USD
    World Rank (Dec-25-2022)
    18,558
    Market Cap (Dec-25-2022)
    0.181 Billion USD
    World Rank (Jan-07-2022)
    15,847
    Market Cap (Jan-07-2022)
    0.34 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -142 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    UK
    Yahoo @ Frankfurt
    Company Profile

    Autolus Therapeutics is a Biopharmaceutical company. The headquarters is in UK.

    Company Website
    AUTOLUS THERAPEUTICS PLC

  3. Kura Oncology

    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -139 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

  4. Intrexon Corporation

    World Rank (Jan-05-2024)
    7,914
    World Rank (Jul-30-2023)
    7,914
    World Rank (Dec-25-2022)
    7,914
    World Rank (Jan-07-2022)
    7,914
    Headquarters Country
    USA
    Company Profile
    Precigen is a Dedicated Discovery and Clinical Stage Biopharmaceutical company. It is advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno oncology, autoimmune disorders and infectious diseases. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 90.7 million USD and 601 employees as on 2020.
    Company Website
    INTREXON CORPORATION

  5. MiMedx Group Inc

    World Rank (Jan-05-2024)
    7,947
    Market Cap (Jan-05-2024)
    1.139 Billion USD
    World Rank (Jul-30-2023)
    9,160
    Market Cap (Jul-30-2023)
    0.921 Billion USD
    World Rank (Dec-25-2022)
    15,405
    Market Cap (Dec-25-2022)
    0.315 Billion USD
    World Rank (Jan-07-2022)
    11,989
    Market Cap (Jan-07-2022)
    0.63 Billion USD
    Annual Revenue in USD
    267 Million USD
    Annual Operating Income in USD
    -25 Million USD
    Annual Net Income in USD
    -37 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ OTC
    Company Profile

    Mimedx Group Annual Total Revenue for year ending Dec-2022 was 267 million USD and and Net loss for year ending Dec-2022 was -36 million USD.

    MiMedx Group Annual Total Revenue for year ending Dec-2021 was 258 million USD and and Net loss for year ending Dec-2021 was -16 million USD.

    As on 2022, MiMedx Group has 867 employees.

    Facts About Company

    Mimedx Group Annual Total Revenue for year ending Dec-2022 was 267 million USD and and Net loss for year ending Dec-2022 was -36 million USD.

    Company Website
    MIMEDX GROUP

  6. Belite Bio Inc

    World Rank (Jan-05-2024)
    7,954
    Market Cap (Jan-05-2024)
    1.137 Billion USD
    World Rank (Jul-30-2023)
    11,043
    Market Cap (Jul-30-2023)
    0.656 Billion USD
    World Rank (Dec-25-2022)
    9,808
    Market Cap (Dec-25-2022)
    0.768 Billion USD
    Headquarters Country
    USA
    Company Profile
    Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on aging metabolic diseases including dry age related macular degeneration, liver disease and diabetes. The headquarters is in United States.
    Company Website
    Belite Bio Inc

  7. Amylyx Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Headquarters Country
    USA
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
    Company Website
    AMYLYX PHARMACEUTICALS, INC.

  8. Zentalis Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,087
    Market Cap (Jan-05-2024)
    1.106 Billion USD
    World Rank (Jul-30-2023)
    5,954
    Market Cap (Jul-30-2023)
    1.885 Billion USD
    World Rank (Dec-25-2022)
    8,174
    Market Cap (Dec-25-2022)
    1.043 Billion USD
    World Rank (Jan-07-2022)
    4,662
    Market Cap (Jan-07-2022)
    3.16 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -227 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Zentalis Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is discovery and development of small molecule therapeutics targeting fundamental biological pathways of cancer. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 7.1 million USD and 71 employees as on 2020.
    Company Website
    ZENTALIS PHARMACEUTICALS, INC.

  9. 89Bio Inc.

    World Rank (Jan-05-2024)
    8,293
    Market Cap (Jan-05-2024)
    1.062 Billion USD
    World Rank (Jul-30-2023)
    7,991
    Market Cap (Jul-30-2023)
    1.162 Billion USD
    World Rank (Dec-25-2022)
    12,003
    Market Cap (Dec-25-2022)
    0.532 Billion USD
    World Rank (Jan-07-2022)
    17,461
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -102 Million USD
    Annual Net Income in USD
    -102 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    89bio is a Clinical Stage Biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio metabolic diseases. The headquarters is in USA.

    Company Website
    89BIO

  10. MannKind Corporation

    World Rank (Jan-05-2024)
    8,442
    Market Cap (Jan-05-2024)
    1.030 Billion USD
    World Rank (Jul-30-2023)
    7,743
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,058
    Market Cap (Dec-25-2022)
    1.340 Billion USD
    World Rank (Jan-07-2022)
    9,303
    Market Cap (Jan-07-2022)
    1.02 Billion USD
    Annual Revenue in USD
    100 Million USD
    Annual Operating Income in USD
    -69 Million USD
    Annual Net Income in USD
    -87 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.
    Company Website
    MANNKIND CORPORATION
    Wikipedia
    Wikipedia

Share